Related by context. All words. (Click for frequent words.) 74 Health Initiative Observational 72 Wisconsin Sleep Cohort 71 Netherlands Cohort Study 69 Framingham Offspring Study 68 NHANES III 68 Prostate Lung Colorectal 67 CARDIA 67 prospective cohort 67 limiting generalizability 66 Atherosclerosis MESA 66 Osteoporotic Fractures 66 CARDIA study 65 PLCO 65 retrospective cohort 65 dietary questionnaires 65 Multi Ethnic Study 65 retrospective cohort study 64 INTERHEART study 64 Screening Trial DMIST 64 observational cohort 63 semistructured interviews 63 GYTS 63 civilian noninstitutionalized population 63 Prostate Cancer Prevention 62 multicentre prospective 62 NHANES surveys 62 Multicenter AIDS 62 THIS STUDY analyzed 62 NLSY 62 Nutrition EPIC 61 Univariate analysis 61 Professionals Follow 61 Digital Mammographic Imaging 61 HIV uninfected 61 acrylamide intake 61 prospective observational 61 aged ≥ 61 Dr. Sara Forhan 61 CHD CVD 61 colorectal bowel 61 nonpregnant women 61 Birth Cohort 61 Young Adults CARDIA 61 Canadian Multicentre Osteoporosis 61 HealthGrades analyzed 60 retrospective observational study 60 sedentary postmenopausal 60 Screening Trial 60 undergone radical prostatectomy 60 Alpha Tocopherol Beta Carotene 60 substudy 60 Early Childhood Longitudinal Study 60 Normative Aging Study 60 SORT OUT III 60 longitudinal cohort study 60 multiple logistic regression 60 EMPHASIS HF trial 60 Atherosclerosis Risk 60 Baseline characteristics 60 relapsed MM 60 NSDUH 60 underwent CABG 60 Ovarian PLCO Cancer 59 CALGB 59 prospective observational cohort 59 Millennium Cohort Study 59 Nord Trøndelag Health 59 myocardial infarctions MIs 59 undergone hysterectomies 59 dysglycemia 59 Framingham Offspring 59 prospective observational studies 59 HIV seronegative 59 Ovarian Cancer Screening 59 SEER database 59 Communities ARIC study 59 NHANES 59 advanced adenoma 59 Medical Expenditure Panel 59 advanced neoplasia 59 Gynecologic Oncology Group 59 postmenopausal women 59 Baltimore Longitudinal Study 59 RE LY ® 59 CHAMPION PCI 59 OPT CHF 59 Study ARIC 59 Replication NCS R 59 Subgroup analyzes 59 Carotid Revascularization Endarterectomy vs. 58 Women Ischemia Syndrome 58 colorectal adenomas 58 Multiethnic Cohort Study 58 AIR CF1 58 nondiabetic 58 Nutritional Examination Survey 58 PLCO trial 58 Urinary incontinence affects 58 underwent radical prostatectomy 58 CVD mortality 58 observational cohort study 58 prospectively defined 58 asymptomatic PAD 58 Rakai Uganda 58 National Birth Cohort 58 colorectal neoplasia 58 PLX STROKE targeting 58 HYVET 58 singleton pregnancies 58 gallstone disease 58 NHANES #-# 58 nulliparous women 58 ICSI cycles 57 COU AA 57 Collaborative Perinatal Project 57 REVIVE Diabetes 57 longitudinal study 57 tanned indoors 57 colorectal cancer incidence 57 Folfox 57 IMPROVE HF 57 European Randomized Study 57 atherothrombotic disease 57 prospective multicentre 57 liver transplant recipients 57 Cohort Consortium 57 NESARC 57 ALSPAC 57 End Results SEER 57 SWiTCH 57 NAMCS 57 RECORD1 57 Dietary Modification Trial 57 AML MDS 57 Kaplan Meier analysis 57 multicenter study 57 Health NSDUH 57 landmark ATHENA 57 vaginal swab specimens 57 invasive MRSA infections 57 SEER registry 57 CAMMS# 57 longitudinal observational study 57 sociodemographic characteristics 57 noninstitutionalized adults 57 TAXUS ARRIVE 57 nondiabetic patients 57 flavonoid intake 57 Homocysteine levels 57 symptomatic BPH 56 CAPRIE 56 fasting serum 56 decompensated liver disease 56 Nutrition Examination 56 antiretroviral naïve 56 histologically confirmed 56 Col. Ralph Kauzlarich 56 Study AREDS 56 Nutrition Examination Surveys 56 microbiologically evaluable 56 older NSAID diclofenac 56 Group B CALGB 56 National Epidemiologic Survey 56 denosumab oncology clinical trials 56 NCT# ClinicalTrials.gov 56 Health Examination Survey 56 beta carotene supplementation 56 CATIE AD 56 DMIST 56 REVIVE TA 56 ICD implants 56 INTERMAP 56 placebo controlled clinical 56 microalbumin test 56 Group RTOG 56 CHD mortality 56 double blinded randomized 56 colorectal adenoma 56 Epidemiologic studies 56 prospective longitudinal 56 ISPO institute 56 Stroke REGARDS study 56 coronary calcification 56 clinico pathological 56 Dialysis Outcomes 56 HORIZONS AMI trial 56 Depression Study TADS 56 attain statistical significance 56 controlled multicenter 56 Memory Study WHIMS 56 postintervention 56 mailed questionnaires 56 Val HeFT 56 T1DM 56 dose escalation phase 56 Kaplan Meier curve 56 histologic subtype 56 Trial PCPT 56 underwent bariatric surgery 56 EXPLORE Xa 56 Subgroup analysis 56 BRFSS 56 treatment naive genotype 56 BR.# 56 episodic migraine sufferers 56 serum lipid levels 56 HIV HCV coinfected 56 placebo controlled clinical trials 55 Avon Longitudinal Study 55 STRIDE PD 55 Related Conditions NESARC 55 heavily pretreated 55 aged between# 55 REGARDS 55 randomized controlled multicenter 55 National Longitudinal Survey 55 Multivariate analysis 55 BPH afflicts approximately 55 underwent liver transplantation 55 placebo controlled Phase III 55 ToGA 55 conducted retrospective cohort 55 attending antenatal clinics 55 serum leptin 55 CARE HF 55 BCIRG 55 ASVAB exam between 55 psychiatric outpatients 55 WHEL 55 definite stent thrombosis 55 recurrent VTE 55 Multicenter Automatic Defibrillator Implantation 55 hydroxyvitamin D levels 55 LibiGel Phase III 55 DCCT 55 Dietary intakes 55 MADIT CRT trial 55 MetS 55 iPrEx study 55 lipid lowering medications 55 Partnership Attitude Tracking 55 liver transplantations 55 Prospective Investigation 55 Secondhand smoke causes 55 Longitudinal studies 55 Multiple logistic regression 55 BRAF mutated 55 EQUIP OB 55 N telopeptide 55 fraternal twin pairs 55 AVAiL 55 Multivariate logistic regression 55 subclinical hypothyroidism 55 univariate analyzes 55 preintervention 55 noninstitutionalized 55 BMD measurements 55 Pneumococcal vaccines 55 ERSPC 55 Birth Defects Prevention 55 Nutrition Examination Surveys NHANES 55 multicenter randomized clinical 55 lifetime abstainers 55 Nutrition Examination Survey NHANES 55 Intervention Trial GAIT 55 highest tertile 55 habitual snoring 55 ELBW infants 55 Felix Asplund 55 prostate cancer CaP 55 KIF6 gene variant 55 cerebral microbleeds 54 Thyroid nodules 54 congenital toxoplasmosis 54 macroglobulinemia 54 GH deficiency 54 Cohort Study 54 Arterial stiffness 54 UKPDS 54 urinary BPA 54 RESIST studies 54 Depressive disorders afflict 54 ESPAD 54 observational study 54 SWOG 54 retrospectively analyzed 54 VADT 54 number NCT# ClinicalTrials.gov 54 multivariate adjustment 54 NCCTG N# 54 Health Initiative WHI 54 Multivariate analyzes 54 ASPS statistics 54 recurrent metastatic 54 pharyngeal cancer 54 MADIT II 54 BMI waist circumference 54 INSPIRE Trial Phase III 54 digit dialed 54 stage IIIb IV 54 dietary calcium intake 54 visceral metastases 54 BMI percentiles 54 abdominal ultrasounds 54 HCV RESPOND 2 54 faulty BRCA2 gene 54 singleton babies 54 Insulin sensitivity 54 Observational studies 54 Nationwide Inpatient Sample 54 Wennmann 54 singleton births 54 clinically evaluable 54 placebo controlled trials 54 BRCA1 mutation carriers 54 THIS STUDY 54 orofacial clefts 54 controlled dose escalation 54 multivariate analyzes 54 familial AF 54 serum vitamin D 54 placebo controlled dose escalation 54 serum selenium 54 HGPIN 54 conditional logistic regression 54 blinded randomized controlled 54 undergoing coronary angiography 54 nonmetastatic 54 malignant mesothelioma Alfacell 54 logistic regression models 54 Rectal cancer 54 prospective randomized multicenter 54 thrombocytopenic 54 Stenting Trial CREST 54 XIENCE V demonstrated 54 elevated hsCRP 54 BRCA gene mutations 54 nondemented 54 precaution Wiehle 54 bivariate analyzes 54 Primary endpoints 54 vertebral fracture 54 Isle Royale wolf 54 meta regression 54 ALLHAT 54 testicular germ cell 54 FG Wahlen surveys 54 cognitively normal 54 Secondary efficacy endpoints 54 undergoing bariatric surgery 54 Globocan 54 multicentre randomized 54 estimated glomerular filtration 54 AIR CF2 54 lignan intake 54 parous women 54 mcg albinterferon alfa 2b 54 Buijsse 54 Jack Pirozzolo 54 ExTRACT TIMI 53 EURIDIS 53 arterial thromboembolic events 53 HER2 expression 53 HPTN 53 Pollster Populus interviewed 53 NO# [002] 53 multivariate logistic regression 53 endometriosis ovarian cysts 53 plasma selenium 53 Children ALSPAC 53 Chronic myeloid leukemia CML 53 multicenter multinational 53 univariate 53 anal HPV 53 USMTC program 53 thyrotropin levels 53 telomere lengths 53 multicentre study 53 lung esophageal 53 elevated LDL cholesterol 53 multicenter placebo controlled 53 familial clustering 53 trials RCTs 53 fasting triglyceride levels 53 narcolepsy cataplexy 53 TAXUS V 53 IPA SBRB poll 53 renal cell carcinomas 53 Interview Survey CHIS 53 prelicensure 53 #OHD levels 53 Liraglutide Effect 53 logistic regression analysis 53 ABSORB clinical 53 AVERROES 53 randomly selected sample 53 ENESTnd 53 overnight polysomnography 53 SYMMETRY trial 53 dietary intakes 53 abnormal lipid levels 53 nonvertebral fractures 53 ONTARGET 53 papillary renal cell carcinoma 53 BMI z 53 APPROVe trial 53 HF ACTION 53 RSD# oral 53 familial aggregation 53 undergone bariatric surgery 53 obese postmenopausal 53 nonfatal MI 53 subgroup analyzes 53 WHIMS 53 seropositivity 53 Complications Trial 53 Tor Bjerkedal report 53 % CI #.#-#.# [003] 53 DAPT Study 53 mg BID dose 53 evaluable subjects 53 multivariable Cox 53 undergone hysterectomy 53 venlafaxine XR 53 plasma folate 53 KIF6 carriers 53 breast cancer recurrences 53 Framingham Heart 53 DBMD 53 Bankruptcies soar 53 Populus interviewed random 53 Surveillance Epidemiology 53 onset diabetes mellitus 53 multivariable logistic regression 53 randomized controlled trials RCTs 53 Logistic regression analysis 53 sociodemographic 53 waist circumferences 53 blinded randomized placebo controlled 53 pexelizumab trials 53 highest quintile 53 ug dose 53 TEAEs 53 HSCT 53 recurrent malignant glioma 53 CC genotype 53 SIMPADICO 53 TG MV 53 AIM HIGH 53 anastrazole 53 plasma homocysteine levels 53 mammography registries 53 System BRFSS 53 oesophageal adenocarcinoma 53 nonfasting triglycerides 53 ELCAP 53 Insulin Resistance Atherosclerosis 53 Atkins dieters cardiovascular 53 serum GGT 53 parous 53 microalbumin 53 Epidemiologic Follow 53 Multiethnic Study 53 BRCA2 mutation carriers 53 Celiac disease affects 53 dietary glycemic index 53 logistic regression model 53 YRBS 53 AIR CF3 53 Polyp Prevention Trial 53 dbGaP 53 Karolinska Institutet Stockholm Sweden 53 VLBW infants 53 Rheumatoid arthritis affects 53 REALITY Trial 53 galiximab 53 ENDEAVOR IV 53 utmost importance Breithaupt 53 Cohort Study MACS 53 darbepoetin alpha 53 serodiscordant couples 53 HER2 overexpression 53 MIVI TRUST 53 receiving antiretroviral therapy 53 calculated creatinine clearance 53 Interview Survey 53 bone density measurements 53 prospective nonrandomized 53 meta analysis pooling 53 logistic regression analyzes 53 dosing cohort 53 infliximab monotherapy 53 atypical hyperplasia 53 VLBW 53 advanced adenomas 53 PRAMS 53 Pull Ups diapers 53 multicenter randomized controlled 53 lipid lowering therapy 53 ORAL Solo 53 segmented regionally 53 relapsing remitting MS RRMS 53 JAMA. 53 Operative mortality 53 achieved ACR# 52 journal Epilepsia 52 AIR2 Trial 52 facial clefts 52 Radiology Imaging Network 52 II Nutrition Cohort 52 prescribed isotretinoin 52 TAXUS VI 52 spontaneous preterm delivery 52 TMC# C# 52 J Immunol 52 operable breast cancer 52 inconclusive Pap 52 INTERMACS 52 elevated ALT 52 Longitudinal Alcohol Epidemiologic 52 MADIT CRT 52 adiponectin concentrations 52 nonrandomized 52 BARI 2D 52 CLARITY TIMI 52 Proellex TM 52 #q#.# deletion syndrome 52 HBeAg negative 52 receiving concomitant corticosteroids 52 psychiatric morbidity 52 anovulatory infertility 52 Gastineau gyms open 52 underwent surgical resection 52 Botswana Lesotho Malawi Mozambique 52 Cochrane Systematic Review 52 NSABP 52 variant rs# 52 intracerebral hemorrhages 52 Peripheral arterial disease 52 azilsartan medoxomil 52 subclinical hyperthyroidism 52 PCPT 52 Uterine cancer 52 hemodialysis patients 52 Statistical analyzes 52 bacterial isolates 52 metastatic HRPC 52 IPAH 52 CALGB # [002] 52 multivariable analysis 52 Edge STudy 52 National Comorbidity Survey 52 CABG surgeries 52 AVADO 52 de novo AML 52 Wactawski Wende 52 Cochrane reviewers 52 chlamydial infection 52 Bayer HealthCare Onyx Pharmaceuticals 52 TRITON TIMI 52 random sample 52 Kaplan Meier estimates 52 baseline serum bilirubin 52 surveys Herbenick 52 folate vitamin B 52 Gestational diabetes affects 52 NCDB 52 inhospital 52 nondepressed 52 Univariate 52 BMI ≥ 52 serum IGF 52 choline intake 52 CYPHER Stent 52 artery calcification 52 hip BMD 52 probands 52 extracolonic findings 52 #rd Annual CTRC 52 HIV seroconversion 52 sleeve lobectomy 52 Household Expenditure Survey 52 VaD 52 ABSORB trial 52 asymptomatic carotid stenosis 52 AI AN 52 HBV infections 52 randomized blinded 52 Celecoxib APC trial 52 antiretroviral naive 52 placebo controlled multicenter 52 Professor Najman 52 ASD prevalence 52 HCV SPRINT 52 TITLE Auctions 52 Saliva samples 52 acute leukemias 52 Physical Therapy PTJ 52 acute myocardial infarctions 52 multicenter Phase III 52 RIO Diabetes 52 ENDEAVOR clinical 52 Regression analyzes 52 ADMIRE HF 52 DAS# CRP 52 Sleep apnea affects 52 premenopausal women 52 seroconverted 52 APOL1 52 abnormal lipid 52 retrospective observational 52 RRMS patients 52 multivariable analyzes 52 Goltz syndrome 52 deCODE AF TM 52 nonfasting triglyceride levels 52 Spira cites 52 pre eclamptic 52 subanalysis 52 B vitamin supplementation 52 myocardial infarction MI 52 pelvic malignancies 52 Nutrition Examination Survey 52 Fatalistic kids 52 test FOBT 52 baseline HbA1c 52 NHAMCS 52 AVOREN 52 Dubbo Osteoporosis Epidemiology 52 underwent percutaneous coronary 52 socioeconomic status SES 52 EchoCRT 52 Survey.com 52 cancerous prostates removed 52 BMI percentile 52 KRAS mutations occur 52 Abdul Karim al Jibouri 52 coronary angiograms 52 HCV infected 52 Routine Paps should 52 gestational hypertension 52 USPSTF recommends 52 Coronary artery calcification 52 HbA1C levels 52 sociodemographic factors 52 Radiation Therapy Oncology 52 randomized trials 52 axillary node 52 practitioners internists 52 PRESEPT 52 actigraphy 52 serum estradiol 52 Logistic regression 52 epidemiologic studies 52 SCD HeFT 52 Moore Theatre tickets.com 52 fasting insulin 52 G#D mutation 52 Study PATS 52 Coronary Artery Risk 52 glucose intolerant 52 GetGoal Phase III 52 Cystic fibrosis affects 52 nonobese 52 suboptimal adherence 52 PRIMO CABG2 52 CoQ# supplementation 52 Sociodemographic 52 MERLIN TIMI 52 socio demographic 52 ACCORD Eye 52 Pharmacokinetic parameters 52 Dose escalation 52 Clogged arteries cause 52 Severe acneform rash 52 SNP rs# [002] 52 Erectile function 52 genetic variants associated 52 riociguat 52 heFH 52 CIMZIA TM certolizumab pegol 52 urolithiasis 52 smoldering myeloma 52 ECG abnormalities 52 EPTA examines employee 52 hematopoietic cancers 52 ragweed allergic 52 ICON7 52 atherothrombosis 51 RTOG 51 liver biopsies 51 prospectively randomized 51 PRECiSE 51 PON1 activity 51 perimenopausal women 51 Waldenstrom macroglobulinemia 51 IFN alfa 51 landmark epidemiologic 51 ICD therapy 51 Low birthweight 51 MGUS 51 PROactive study 51 NCCTG 51 landmark ATHENA study 51 J Clin Oncol 51 NCI Surveillance Epidemiology 51 Tickbox.net 51 Epidemiological studies 51 dapagliflozin plus 51 Clinical Antipsychotic Trials 51 treatment naïve genotype 51 premenopausal 51 null responder HCV 51 CLBP 51 specific antigen PSA 51 multicentre 51 BRCA mutation carriers 51 univariate analysis 51 elevated serum ALT 51 baseline PASI 51 Slone Epidemiology Center 51 ACOSOG Z# 51 ovarian endometrial 51 elective percutaneous coronary 51 glioma tumors 51 cryptorchidism 51 susceptibility loci 51 familial pancreatic cancer 51 multicenter 51 intravenous CK # 51 EDSS score 51 histologically proven 51 EMPOWER ™ 51 linear regression analyzes 51 Meta analyzes 51 randomized crossover 51 observational studies 51 containing drospirenone 51 Cholesterol Levels SPARCL 51 intravenous RSD# 51 de aths 51 uninfected infants 51 PCI ExTRACT TIMI 51 #q# deletion syndrome 51 nonmarital births 51 anti JCV antibodies 51 RCTs 51 Phase III metastatic melanoma 51 normotensive 51 perioperative complications 51 ACUITY trial 51 Membership fluctuates 51 malignant neoplasm 51 Ocular Hypertension Treatment 51 journal Gynecologic Oncology 51 ductal breast cancer 51 MERIT ES 51 Arch Intern Med 51 APEX AMI trial 51 Endocrine Society #st 51 STEP BD 51 distal colon cancer 51 GISSI HF 51 Hb A1C 51 ConclusionThis 51 Renal Data 51 comorbid illnesses 51 drank pomegranate juice 51 anthropometric measurements 51 LUX Lung 51 metastatic GIST 51 inhibin B 51 Activity Limitation 51 GPC5 51 oral FTY# 51 Postoperative complications 51 hip resurfacing arthroplasty 51 prior chemotherapy regimens 51 Charlson comorbidity index 51 studies GWAS 51 ComRes telephoned 51 medulloblastoma tumors 51 folate intake 51 abnormal cytology 51 Kaplan Meier estimate 51 biochemical relapse 51 defendant Vincenzo Cannalire 51 serum uric acid 51 Factor Surveillance 51 refractory metastatic 51 Harpo Studios produces 51 Euro Libor #.# 51 Charles Dullin School 51 recurrent UTI 51 ICDs implanted 51 tumor histology 51 randomized controlled trials 51 undergoing androgen deprivation 51 PREZISTA r arm 51 carotid plaque 51 kidneys transplanted 51 perinatal morbidity 51 invasive carcinoma 51 aneurysmal subarachnoid hemorrhage 51 CONQUER OB 51 Neuroepidemiology 51 Index CDAI 51 subclinical atherosclerosis 51 biochemical recurrence 51 malignant polyps 51 iniparib BSI 51 hemoglobin A1c HbA1c 51 Diabetes ACCORD 51 heterosexually acquired 51 postmenopausal 51 BLLs 51 Pollster ICM interviewed 51 colorectal neoplasms 51 biomonitoring studies 51 Sudha Seshadri MD 51 adolescent females 51 YRC Worldwide employs 51 PROPEL trial 51 thromboembolic 51 FDG PET scans 51 internalizing disorders 51 lipid lowering drugs 51 elevated fasting glucose 51 gynecologic malignancy 51 fetal chromosomal 51 PARTNER Trial 51 basal cell nevus syndrome 51 venous thromboembolisms 51 INTERPHONE 51 serum lipids 51 ABCSG 51 genotypic resistance 51 FluCAM arm 51 multicentric 51 Bipolar disorder affects 51 undergoing coronary artery 51 Relapsing remitting MS 51 BRCA1 mutations 51 homocysteine concentrations 51 SPIRIT III 51 prospectively stratified 51 #.#ng/ml 51 persistent wheezing 51 Platelet counts 51 tertiles 51 detected cyber espionage 51 overt hepatic encephalopathy HE 51 Ciccarone Preventive Cardiology 51 thorough QT 51 hormone receptor negative 51 prospective multicenter study 51 clinically localized prostate 51 underwent resection 51 BRCA2 mutations 51 HIES 51 % CI #.#-#.# [008] 51 journal Liver Transplantation 51 intra abdominal abscess 51 Farman terrorized 51 atazanavir ritonavir 51 azoospermia 51 CR nPR 51 overweight sedentary 51 acute myeloid 51 coronary revascularizations 51 Educational Longitudinal Study 51 blind multicenter 51 Phase IIIb study 51 CALERIE 51 ductal carcinomas 51 mammographic density 51 HBeAg negative patients 51 meta analysis 51 postmenopausal hormone therapy 51 diagnostic angiography 51 neurocognitive functioning 51 Recommended Dietary Allowance RDA 51 adenomatous polyps 51 coronary artery calcification 51 acute lymphoid leukemia 51 Listeria infections 51 Multivariable logistic regression 51 odds ratios ORs 51 PRESEPT study 51 BCG vaccinated 51 NNRTI resistance 50 Nephrology Dialysis Transplantation 50 psychiatric comorbidities 50 postmenopausal hormones 50 Postpartum depression affects 50 squamous cell histology 50 multicenter Phase II 50 #mg/day [001] 50 LV dysfunction 50 nadroparin 50 CTA# Injection 50 seronegative 50 bepotastine besilate nasal spray 50 ongoing Phase IIIb 50 SEER registries 50 deCODE ProstateCancer TM 50 clinical pharmacology studies 50 untreated hypothyroidism 50 Peptide YY 50 NYHA functional class 50 ischemic strokes 50 symptomatic pulmonary embolism 50 dial +#-#-#-# [003] 50 pCR 50 ECASS 50 dietary fiber intake 50 CLIRS 50 RPGEH 50 Birth Registry 50 Vital Statistics System 50 lactose malabsorption 50 #,# WeddingWire newlyweds 50 glycated hemoglobin levels 50 PRIMO CABG 50 Archangel Archive crew 50 recurrent coronary 50 PreCISe study 50 CDKN2A 50 Kaplan Meier 50 mITT 50 Arch Surg 50 heterozygous familial hypercholesterolemia 50 randomized clinical trials 50 preserved LVEF 50 screening colonoscopy 50 mcg linaclotide 50 posttreatment 50 androgen suppression 50 preserved ejection fraction 50 REFORMERS UNANIMOUS Weekly 50 recurrent venous thromboembolism 50 Education Next PEPG 50 Sylvia Wassertheil Smoller 50 undergone splenectomy 50 nationally projectable 50 neovascular form 50 APPRAISE 50 microscopic colitis 50 R# #mg BID 50 Refinery utilization rebounded 50 unstable angina pectoris 50 Folate deficiency 50 KRAS gene mutations 50 randomized multicenter 50 mg administered orally 50 Hp2 2 50 Phase III randomized controlled 50 Stacy Tessler Lindau 50 confirmatory clinical 50 detectable BPA 50 schizophrenia schizoaffective disorder 50 journal Circulation Cardiovascular 50 impaired insulin secretion 50 BARACLUDE ® 50 unsupplemented 50 underwent brachytherapy 50 preoperative radiotherapy 50 colorectal polyp 50 myocardial infarctions 50 GPNMB expression 50 umol L 50 Munk Olsen 50 CHDs 50 MAGE A3 ASCI 50 Bacille Calmette Guérin BCG 50 mean ± SEM 50 HORIZONS AMI 50 rheumatology clinics 50 polyp recurrence 50 MELD scores 50 generalizability 50 invasive cervical cancers 50 multicenter prospective 50 HCUP 50 LUMINATE 50 Endeavor Resolute DES 50 Randomized trials 50 CaPSURE 50 confidence interval #.#-#.# 50 estrogen progestin therapy 50 oral clefts 50 Previous epidemiological studies 50 potential confounders 50 CYPHER R stent 50 WTCCC 50 phylloquinone 50 lipid lowering medication 50 Simin Nikbin Meydani 50 drank decaffeinated coffee